If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

Share Price is delayed by 15 minutes
Get Live Data
26.30    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.60 (2.344%)
Market Cap: £113.16m
EKF Live PriceLast checked at - London Stock Exchange

Intraday Ekf Diagnostics Share Chart

PDMR dealing

19 Dec 2018 16:56

RNS Number : 0335L
EKF Diagnostics Holdings PLC
19 December 2018
 

 

 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

PDMR dealing

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-traded medical diagnostics business, announces that on 19 December 2018, the Company was notified by Mike Salter (President, Americas) that he has today purchased 125,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares").

 

 

EKF Diagnostics Holdings plc

www.ekfdiagnostics.com

Christopher Mills, Non-Executive Chairman

Tel: 029 2071 0570

Julian Baines, CEO 

Richard Evans, FD & COO

N+1 Singer (Nomad & Broker)

Tel: 020 7496 3000

Aubrey Powell / George Tzimas / Carlo Spingardi (Corporate Finance)

Tom Salvesen (Corporate Broking)

Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com

Paul McManus/ Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Mike Salter

2

 

Reason for the notification

 

a)

 

Position/status

 

 

President, Americas

 

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

EKF Diagnostics Holdings plc

b)

 

LEI

 

 

213800DXTF3EAUK1AR05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each ("Ordinary Shares")

 

 

ISIN Code: GB0031509804

 

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

24.75p

 

125,000

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

n/a

e)

 

Date of the transaction

 

 

19 December 2018

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFFLFMUFASEIE
Date   Source Headline
18th Jan 20164:35 pmRNSPrice Monitoring Extension
18th Jan 201611:56 amRNSHolding(s) in Company
15th Jan 20163:11 pmRNSHolding(s) in Company
23rd Dec 20157:00 amRNSSale of Selah
22nd Dec 20152:17 pmRNSFundraising
21st Dec 20157:00 amRNSAppointment of a Director
14th Dec 201512:51 pmRNSDirector/PDMR Shareholding
10th Dec 20157:00 amRNSDirectorate Changes
9th Dec 20154:46 pmRNSHolding(s) in Company
2nd Dec 20152:39 pmRNSDirectorate Changes
30th Nov 20155:39 pmRNSHolding(s) in Company
30th Nov 20157:00 amRNSDirectorate Changes
26th Nov 20157:00 amRNSTrading update
20th Nov 20152:55 pmRNSDeath of Director
12th Nov 20154:35 pmRNSPrice Monitoring Extension
12th Nov 20157:00 amRNSConsolidation of manufacturing sites
11th Nov 20157:00 amRNSDirectorate Change
9th Nov 20157:00 amRNSBiomarker data predicting diabetic kidney disease
6th Nov 20157:00 amRNSSelah consideration update
23rd Oct 20155:06 pmRNSStrategic Update
23rd Oct 20154:58 pmRNSOffer Talks Terminated
23rd Oct 201510:14 amPRNForm 8.3 - EKF Diagnostics Holdings Plc
22nd Oct 20152:37 pmRNSForm 8.3 - [EKF Diagnostics Holdings plc]
22nd Oct 20152:26 pmRNSForm 8.3 re Zwanziger Family re EKF Diagnostics
21st Oct 20154:46 pmRNSForm 8.3 re Zwanziger Family re EKF Diagnostics
19th Oct 201511:59 amRNSForm 8.3 - Zwanziger Family Ventures LLC
19th Oct 20157:00 amRNSExtension to deadline under Rule 2.6(c)
15th Oct 20157:00 amRNSPointMan used in liquid biopsy research study
13th Oct 20153:07 pmRNSForm 8.3 - [EKF Diagnostics Holdings plc]
12th Oct 201511:48 amRNSForm 8.3 - EKF Diagnostics Holdings plc
2nd Oct 201510:54 amPRNForm 8.3 - EKF Diagnostic Holdings Plc
1st Oct 20155:04 pmRNSForm 8.3 - EKF Diagnostics Holdings PLC
1st Oct 201510:10 amPRNForm 8.3 - EKF Diagnostics Holdings Plc
30th Sep 20151:18 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
29th Sep 20151:33 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
28th Sep 20157:00 amRNSHalf Yearly Report
24th Sep 20151:33 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
24th Sep 201512:21 pmRNSForm 8.3-EKF Diagnostics Hldng PLC-Replacement
23rd Sep 20154:35 pmRNSForm 8.3 - EKF Diagnostics Holdings PLC
18th Sep 20157:00 amRNSNew data published on PointMan
18th Sep 20157:00 amRNSOffer Update
9th Sep 20157:00 amRNSForm 8.3 - EKF Diagnostics Holdings PLC
8th Sep 20159:39 amRNSWebsite Details for Company Announcements
7th Sep 20157:00 amRNSForm 8 (OPD) EKF Diagnostics Holdings plc
7th Sep 20157:00 amRNSStatement Regarding EKF Diagnostics Holdings plc
3rd Sep 20156:07 pmRNSForm 8.3 - EKF Diagnostics Holdings plc
3rd Sep 20157:00 amRNSNew tender wins for Hemo Control
2nd Sep 201510:54 amRNSForm 8 (OPD) (EKF Diagnostics Holdings plc)
28th Aug 201510:46 amRNSForm 8.3 - EKF Diagnostics Holdings plc
27th Aug 20151:22 pmRNSForm 8.3 - EKF Diagnostics Holdings plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.